Literature DB >> 15381267

Differentiation of Actinobacillus pleuropneumoniae by PCR-REA based on sequence variability of the apxIVA gene and by ribotyping.

Zoran Jaglic1, Petra Svastova, Ivan Rychlik, Katerina Nedbalcova, Zdenka Kucerova, Ivo Pavlik, Milan Bartos.   

Abstract

During the period of 2001-2003, a total of 591 Actinobacillus pleuropneumoniae field isolates from the Czech Republic were serotyped with a high occurrence of cross-reactions. The cross-reactions were observed in 416 isolates. Most frequently, in 401 isolates (67.9%), cross-reactions with antisera specific for serotypes 9, 11, and/or 1 were observed. Two additional molecular methods, ribotyping and restriction analysis of PCR amplified apxIVA gene (PCR-REA), were therefore used for detailed characterisation of A. pleuropneumoniae. In this subsequent analysis, reference strains representing serotypes 1-12 and 25 field isolates showing the most frequent serotype cross-reactions were examined. PCR-REA enabled all reference strains to be distinguished except for the strains of serotypes 9 and 11. Ribotyping distinguished all reference strains except two pairs of serotypes: 3 versus 6, and 9 versus 11, respectively. Field isolates with serotype cross-reactivity 9, 11, and/or 1 could not be differentiated by either of these methods.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15381267     DOI: 10.1016/j.vetmic.2004.07.010

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  2 in total

1.  Multiplex PCR that can distinguish between immunologically cross- reactive serovar 3, 6, and 8 Actinobacillus pleuropneumoniae strains.

Authors:  L Zhou; S C P Jones; Ø Angen; J T Bossé; J H E Nash; J Frey; R Zhou; H C Chen; J S Kroll; A N Rycroft; P R Langford
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

2.  DNA microarray-based identification and typing of Actinobacillus pleuropneumoniae.

Authors:  GuoSheng Xiao; SanJie Cao; XiaoBo Huang; XinTian Wen
Journal:  Can J Vet Res       Date:  2009-07       Impact factor: 1.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.